174 related articles for article (PubMed ID: 33866410)
1. Circular RNA profiling distinguishes medulloblastoma groups and shows aberrant RMST overexpression in WNT medulloblastoma.
Rickert D; Bartl J; Picard D; Bernardi F; Qin N; Lovino M; Puget S; Meyer FD; Mahoungou Koumba I; Beez T; Varlet P; Dufour C; Fischer U; Borkhardt A; Reifenberger G; Ayrault O; Remke M
Acta Neuropathol; 2021 Jun; 141(6):975-978. PubMed ID: 33866410
[No Abstract] [Full Text] [Related]
2. DNA-methylation profiling discloses significant advantages over NanoString method for molecular classification of medulloblastoma.
Korshunov A; Chavez L; Northcott PA; Sharma T; Ryzhova M; Jones DTW; von Deimling A; Pfister SM; Kool M
Acta Neuropathol; 2017 Dec; 134(6):965-967. PubMed ID: 29027579
[No Abstract] [Full Text] [Related]
3. Medulloblastoma: Molecular Classification-Based Personal Therapeutics.
Archer TC; Mahoney EL; Pomeroy SL
Neurotherapeutics; 2017 Apr; 14(2):265-273. PubMed ID: 28386677
[TBL] [Abstract][Full Text] [Related]
4. TERT promoter mutation and aberrant hypermethylation are associated with elevated expression in medulloblastoma and characterise the majority of non-infant SHH subgroup tumours.
Lindsey JC; Schwalbe EC; Potluri S; Bailey S; Williamson D; Clifford SC
Acta Neuropathol; 2014 Feb; 127(2):307-9. PubMed ID: 24337442
[No Abstract] [Full Text] [Related]
5. DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies.
Schwalbe EC; Williamson D; Lindsey JC; Hamilton D; Ryan SL; Megahed H; Garami M; Hauser P; Dembowska-Baginska B; Perek D; Northcott PA; Taylor MD; Taylor RE; Ellison DW; Bailey S; Clifford SC
Acta Neuropathol; 2013 Mar; 125(3):359-71. PubMed ID: 23291781
[TBL] [Abstract][Full Text] [Related]
6. RBM5 Acts as Tumor Suppressor in Medulloblastoma through Regulating Wnt/β-Catenin Signaling.
Yu J; Ji G; Shi W; Zhao R; Shen W; Zheng J; Li H; Jiang F
Eur Neurol; 2020; 83(3):242-250. PubMed ID: 32610314
[TBL] [Abstract][Full Text] [Related]
7. Approach to molecular subgrouping of medulloblastomas: Comparison of NanoString nCounter assay versus combination of immunohistochemistry and fluorescence in-situ hybridization in resource constrained centres.
Kaur K; Jha P; Pathak P; Suri V; Sharma MC; Garg A; Suri A; Sarkar C
J Neurooncol; 2019 Jul; 143(3):393-403. PubMed ID: 31104222
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation profiling is a method of choice for molecular verification of pediatric WNT-activated medulloblastomas.
Korshunov A; Sahm F; Zheludkova O; Golanov A; Stichel D; Schrimpf D; Ryzhova M; Potapov A; Habel A; Meyer J; Lichter P; Jones DTW; von Deimling A; Pfister SM; Kool M
Neuro Oncol; 2019 Feb; 21(2):214-221. PubMed ID: 30252101
[TBL] [Abstract][Full Text] [Related]
9. Medulloblastoma with transitional features between Group 3 and Group 4 is associated with good prognosis.
Łastowska M; Trubicka J; Niemira M; Paczkowska-Abdulsalam M; Karkucińska-Więckowska A; Kaleta M; Drogosiewicz M; Perek-Polnik M; Krętowski A; Cukrowska B; Grajkowska W; Dembowska-Bagińska B; Matyja E
J Neurooncol; 2018 Jun; 138(2):231-240. PubMed ID: 29427151
[TBL] [Abstract][Full Text] [Related]
10. WNT/β-catenin pathway activation in Myc immortalised cerebellar progenitor cells inhibits neuronal differentiation and generates tumours resembling medulloblastoma.
Rogers HA; Sousa S; Salto C; Arenas E; Coyle B; Grundy RG
Br J Cancer; 2012 Sep; 107(7):1144-52. PubMed ID: 22929883
[TBL] [Abstract][Full Text] [Related]
11. Signaling pathway and molecular subgroups of medulloblastoma.
Li KK; Lau KM; Ng HK
Int J Clin Exp Pathol; 2013; 6(7):1211-22. PubMed ID: 23826403
[TBL] [Abstract][Full Text] [Related]
12. Medulloblastoma Genotype Dictates Blood Brain Barrier Phenotype.
Phoenix TN; Patmore DM; Boop S; Boulos N; Jacus MO; Patel YT; Roussel MF; Finkelstein D; Goumnerova L; Perreault S; Wadhwa E; Cho YJ; Stewart CF; Gilbertson RJ
Cancer Cell; 2016 Apr; 29(4):508-522. PubMed ID: 27050100
[TBL] [Abstract][Full Text] [Related]
13. Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays.
Hovestadt V; Remke M; Kool M; Pietsch T; Northcott PA; Fischer R; Cavalli FM; Ramaswamy V; Zapatka M; Reifenberger G; Rutkowski S; Schick M; Bewerunge-Hudler M; Korshunov A; Lichter P; Taylor MD; Pfister SM; Jones DT
Acta Neuropathol; 2013 Jun; 125(6):913-6. PubMed ID: 23670100
[No Abstract] [Full Text] [Related]
14. Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia.
Eberhart CG; Kratz J; Wang Y; Summers K; Stearns D; Cohen K; Dang CV; Burger PC
J Neuropathol Exp Neurol; 2004 May; 63(5):441-9. PubMed ID: 15198123
[TBL] [Abstract][Full Text] [Related]
15. Ginsenoside Rh2 inhibits proliferation and migration of medulloblastoma Daoy by down-regulation of microRNA-31.
Chen Y; Shang H; Zhang S; Zhang X
J Cell Biochem; 2018 Aug; 119(8):6527-6534. PubMed ID: 29377269
[TBL] [Abstract][Full Text] [Related]
16. Overexpressed TP73 induces apoptosis in medulloblastoma.
Castellino RC; De Bortoli M; Lin LL; Skapura DG; Rajan JA; Adesina AM; Perlaky L; Irwin MS; Kim JY
BMC Cancer; 2007 Jul; 7():127. PubMed ID: 17626635
[TBL] [Abstract][Full Text] [Related]
17. Prognostic classification of pediatric medulloblastoma based on chromosome 17p loss, expression of MYCC and MYCN, and Wnt pathway activation.
Park AK; Lee SJ; Phi JH; Wang KC; Kim DG; Cho BK; Haberler C; Fattet S; Dufour C; Puget S; Sainte-Rose C; Bourdeaut F; Grill J; Delattre O; Kim SK; Park WY
Neuro Oncol; 2012 Feb; 14(2):203-14. PubMed ID: 22090452
[TBL] [Abstract][Full Text] [Related]
18. A molecular fingerprint for medulloblastoma.
Lee Y; Miller HL; Jensen P; Hernan R; Connelly M; Wetmore C; Zindy F; Roussel MF; Curran T; Gilbertson RJ; McKinnon PJ
Cancer Res; 2003 Sep; 63(17):5428-37. PubMed ID: 14500378
[TBL] [Abstract][Full Text] [Related]
19. Medulloblastoma genomics in the modern molecular era.
Kumar R; Liu APY; Northcott PA
Brain Pathol; 2020 May; 30(3):679-690. PubMed ID: 31799776
[TBL] [Abstract][Full Text] [Related]
20. Human hedgehog interacting protein expression and promoter methylation in medulloblastoma cell lines and primary tumor samples.
Shahi MH; Afzal M; Sinha S; Eberhart CG; Rey JA; Fan X; Castresana JS
J Neurooncol; 2011 Jun; 103(2):287-96. PubMed ID: 20853133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
